NanoAids.net
About NanoAids.net
The Food and Drug Administration said Tuesday an HIV drug from Pfizer appears safe for expanded use in patients who have not already taken other drugs to combat the virus. However, the FDA said Pfizer studies paint a mixed picture of its drug's effectiveness. A 48-week study comparing Selzentry to Bristol-Myers Squibb's Sustiva failed to meet the goal of showing Pfizer's drug was at least as effective at suppressing HIV. When Pfizer reanalyzed the ...
